TY - JOUR
T1 - Involvement of a novel Rac/RhoA guanosine triphosphatase-nuclear factor-κB inducing kinase signaling pathway mediating angiotensin II-induced RelA transactivation
AU - Choudhary, Sanjeev
AU - Lu, Muping
AU - Cui, Ruwen
AU - Brasier, Allan R.
PY - 2007/9
Y1 - 2007/9
N2 - Angiotensin II (Ang II) is the major effector peptide of the renin angiotensin system that induces inflammatory gene expression through the nuclear factor-κB (NF-κB) transcription factor. Activation of latent cytoplasmic NF-κB is controlled by distinct pathways, the best known being the canonical pathway controlling IκB kinase activation. Interestingly, Ang II only weakly activates the canonical pathway. Although basal nucleocytoplasmic RelA shuttling is required for Ang II stimulation, changes in RelA translocation do not account for its transcriptional effect. Instead, Ang II rapidly induced RelA phosphorylation at Ser residue 536, and complex formation with the Ser536 kinase known as the NF-κB-inducing kinase (NIK)/MEKK14. The requirement of NIK in Ang II-inducible transcription was shown by expressing a dominant-negative NIK or small interfering RNA (siRNA)-mediated knockdown; both inhibited Ang II-induced transcription. Conversely, constitutively active NIK potently induced RelA transactivation activity. Consistent with its actions independent of the canonical pathway, NIK induces the activity of the RelA transactivation domains -1 and -2 in constitutively nuclear GAL4-RelA fusion proteins that do not bind IκBα. Ang II induces NIK activity, phosphorylation of its endogenous IκB kinase α substrate, and induction of nuclear NF-κB2 (p52) processing. NIK down-regulation prevents Ang II-induced phospho-Ser 536 RelA formation, indicating that it is essential for RelA activation. The Ang II pathway further involves the RhoA small GTP-binding protein because RhoA inhibition blocks Ang II-induced transcriptional activity and formation of phospho-Ser536 RelA formation. Finally, we demonstrate that Ang II infusion in vivo rapidly induces phospho-Ser 536 RelA formation and activation of the NF-κB-dependent IL-6 gene. These data indicate that Ang II induces NF-κB-dependent transcription through an alternative pathway, being largely independent of IκB proteolysis, but mediated by the small GTPases Rac/RhoA, required for NIK·RelA complex formation and inducible Ser536 RelA phosphorylation.
AB - Angiotensin II (Ang II) is the major effector peptide of the renin angiotensin system that induces inflammatory gene expression through the nuclear factor-κB (NF-κB) transcription factor. Activation of latent cytoplasmic NF-κB is controlled by distinct pathways, the best known being the canonical pathway controlling IκB kinase activation. Interestingly, Ang II only weakly activates the canonical pathway. Although basal nucleocytoplasmic RelA shuttling is required for Ang II stimulation, changes in RelA translocation do not account for its transcriptional effect. Instead, Ang II rapidly induced RelA phosphorylation at Ser residue 536, and complex formation with the Ser536 kinase known as the NF-κB-inducing kinase (NIK)/MEKK14. The requirement of NIK in Ang II-inducible transcription was shown by expressing a dominant-negative NIK or small interfering RNA (siRNA)-mediated knockdown; both inhibited Ang II-induced transcription. Conversely, constitutively active NIK potently induced RelA transactivation activity. Consistent with its actions independent of the canonical pathway, NIK induces the activity of the RelA transactivation domains -1 and -2 in constitutively nuclear GAL4-RelA fusion proteins that do not bind IκBα. Ang II induces NIK activity, phosphorylation of its endogenous IκB kinase α substrate, and induction of nuclear NF-κB2 (p52) processing. NIK down-regulation prevents Ang II-induced phospho-Ser 536 RelA formation, indicating that it is essential for RelA activation. The Ang II pathway further involves the RhoA small GTP-binding protein because RhoA inhibition blocks Ang II-induced transcriptional activity and formation of phospho-Ser536 RelA formation. Finally, we demonstrate that Ang II infusion in vivo rapidly induces phospho-Ser 536 RelA formation and activation of the NF-κB-dependent IL-6 gene. These data indicate that Ang II induces NF-κB-dependent transcription through an alternative pathway, being largely independent of IκB proteolysis, but mediated by the small GTPases Rac/RhoA, required for NIK·RelA complex formation and inducible Ser536 RelA phosphorylation.
UR - http://www.scopus.com/inward/record.url?scp=34548351303&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548351303&partnerID=8YFLogxK
U2 - 10.1210/me.2006-0465
DO - 10.1210/me.2006-0465
M3 - Article
C2 - 17595324
AN - SCOPUS:34548351303
SN - 0888-8809
VL - 21
SP - 2203
EP - 2217
JO - Molecular Endocrinology
JF - Molecular Endocrinology
IS - 9
ER -